Gilead officer plans sale of 3,000 shares

GILEAD SCIENCES, INC.

Available on EDGAR 09/15/2026 - 04:05 PM EDT Accepted by SEC EDGAR 09/15/2026 - 04:04 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

GILEAD SCIENCES, INC. (GILD) received a Rule 144 notice from officer Andrew Dickinson covering a proposed sale of 3,000 shares of common stock. The shares, held in an account at Morgan Stanley Smith Barney LLC Executive Financial Services, have an indicated aggregate market value of $435,870.00 and are listed on NASDAQ.

The shares to be sold were acquired as Performance Shares from the issuer on January 31, 2024. Dickinson also reports prior Rule 144 sales of 3,000 shares on July 15, 2026 for $389,776.80 and 3,000 shares on August 17, 2026 for $415,080.00 within the preceding three months.

Key Figures

Shares proposed for sale: 3,000 shares Aggregate market value (proposed sale): $435,870.00 Shares acquired as Performance Shares: 3,000 shares +4 more

7 metrics

Shares proposed for sale 3,000 shares Common stock covered by the Rule 144 notice

Aggregate market value (proposed sale) $435,870.00 Value of 3,000 common shares reported in the securities information section

Shares acquired as Performance Shares 3,000 shares Common stock acquired from issuer on January 31, 2024

Shares sold July 15, 2026 3,000 shares Common stock sale reported in past 3 months section

Proceeds from July 15, 2026 sale $389,776.80 Aggregate sale price for 3,000 shares

Shares sold August 17, 2026 3,000 shares Common stock sale reported in past 3 months section

Proceeds from August 17, 2026 sale $415,080.00 Aggregate sale price for 3,000 shares

Key Terms

Rule 144, Performance Shares, aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Performance Shares financial

"Common | 01/31/2024 | Performance Shares | ISSUER"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

aggregate market value financial

"Common ... | 3000 | 435870.00 | 1239955155 | 09/15/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing report for GILD and Andrew Dickinson?

The Form 144 reports that Andrew Dickinson, an officer of Gilead Sciences (GILD), has filed notice of intent to sell 3,000 shares of common stock under Rule 144, with an indicated aggregate market value of $435,870.00 through an account at Morgan Stanley Smith Barney LLC.

How many GILD shares are proposed to be sold under this Form 144?

The notice covers a proposed sale of 3,000 shares of Gilead Sciences common stock. These shares are reported as being held in a Morgan Stanley Smith Barney LLC Executive Financial Services account and are listed as NASDAQ-traded common shares.

What prior GILD share sales does Andrew Dickinson report in the last three months?

Andrew Dickinson reports two prior sales: 3,000 shares on July 15, 2026 for $389,776.80, and 3,000 shares on August 17, 2026 for $415,080.00, both involving Gilead Sciences common stock.

What is the reported market value of the GILD shares covered by this Form 144?

The 3,000 Gilead Sciences common shares covered by the notice have a reported aggregate market value of $435,870.00. This figure is listed in the securities information section associated with the proposed sale on NASDAQ.

How and when were the GILD shares to be sold acquired by Andrew Dickinson?

The shares to be sold were acquired as Performance Shares from the issuer on January 31, 2024, according to the securities-to-be-sold section, which identifies the security as common stock and the acquisition method as an issuer grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001310204
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GILEAD SCIENCES, INC.
SEC File Number	000-19731
Address of Issuer	333 Lakeside Drive Foster City CALIFORNIA 94404
Phone	(650) 574-3000
Name of Person for Whose Account the Securities are To Be Sold	ANDREW DICKINSON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	435870.00	1239955155	09/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2024	Performance Shares	ISSUER			3000	01/31/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANDREW DICKINSON 333 Lakeside Drive Foster City CA 94404	Common	08/17/2026	3000	415080.00
ANDREW DICKINSON 333 Lakeside Drive Foster City CA 94404	Common	07/15/2026	3000	389776.80

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/29/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Andrew D Dickinson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)